Polaris International Holdings (PIHN)

[Kirby46686]

Polaris International Holdings, Inc.'s line ProCannas focuses on the manufacture and distribution of new, pharmaceutical grade cannabinoid based products for medicinal use. With the Joint Venture 70 acre hemp farm in Kentucky, the Company will grow and develop a large portion of its own hemp products. Due to the concentrated strength and unique mix of ingredients integrated within our products, they are intended to be available to patients only through licensed participating physicians. Due to recent changes in the law regarding the medical use of marijuana, coupled with studies and a strong body of evidence highlighting that THC is not the significant component for medicinal use, doors are opening for innovation. Laws are expected to become even more favorable for companies like ProCannas. The Company intends to target a broad range of specialties with this novel product, including but not limited to sports medicine, pain management, neurology, and osteopathic medicine.